Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | ARVN | CLDX | ||
| Company | Vericel Corporation | Arvinas Inc | Celldex Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.06 | 33.42 | 39.41 | ||
| High | 46.56 | 34.46 | 39.94 | ||
| Low | 43.85 | 32.61 | 38.68 | ||
| Last | 44.01 | 34.12 | 38.75 | ||
| Change | -2.25 | +0.67 | -0.88 | ||
| % Change | -4.86% | +2.00% | -2.22% | ||
| Volume | 171,185 | 509,712 | 176,151 | ||
| 20-Day Average Volume | 442,178 | 521,723 | 641,991 | ||
| Previous Close | 46.26 | 33.45 | 39.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 49.26 | 38.24 | 40.36 | ||
| 20-Day Raw Stochastic | 0.00% | 12.95% | 12.22% | ||
| 20-Day Relative Strength | 39.85% | 33.11% | 44.14% | ||
| Weighted Alpha | +40.23 | -18.79 | -5.28 | ||
| Today's Opinion | 56% Buy | 8% Buy | 24% Buy | ||
| Previous Opinion | 56% Buy | 8% Buy | 40% Buy | ||
| Last Month's Opinion | 80% Buy | 56% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.00% since 04/11/24 | -8.23% since 04/11/24 | -5.19% since 04/11/24 | ||
| Low | 43.85 on 04/18/24 | 32.61 on 04/18/24 | 38.14 on 04/16/24 | ||
| High | 49.24 on 04/15/24 | 38.56 on 04/12/24 | 40.86 on 04/12/24 | ||
| 1-Month | |||||
| %Chg | -0.77% since 03/18/24 | -19.73% since 03/18/24 | -5.40% since 03/18/24 | ||
| Low | 43.85 on 04/18/24 | 32.61 on 04/18/24 | 38.10 on 04/10/24 | ||
| High | 53.05 on 04/01/24 | 44.85 on 03/21/24 | 43.42 on 03/21/24 | ||
| 3-Month | |||||
| %Chg | +11.98% since 01/18/24 | -6.01% since 01/18/24 | -2.29% since 01/18/24 | ||
| Low | 38.69 on 01/19/24 | 32.61 on 04/18/24 | 34.65 on 02/02/24 | ||
| High | 53.05 on 04/01/24 | 53.08 on 02/16/24 | 53.18 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +27.14% since 10/18/23 | +122.33% since 10/18/23 | +61.46% since 10/18/23 | ||
| Low | 32.28 on 11/09/23 | 13.57 on 10/27/23 | 22.11 on 10/30/23 | ||
| High | 53.05 on 04/01/24 | 53.08 on 02/16/24 | 53.18 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,238,059 | 2,277,410 | 2,215,357 | ||
| Shares Outstanding, K | 48,380 | 68,084 | 55,901 | ||
| Annual Sales | 197,520,000 | 78,500,000 | 6,880,000 | ||
| Annual Net Income | -3,180,000 | -367,300,000 | -141,430,000 | ||
| Last Quarter Sales | 65,000,000 | 34,600,000 | 4,130,000 | ||
| Last Quarter Net Income | 12,990,000 | -64,000,000 | -43,310,000 | ||
| 60-Month Beta | 1.71 | 1.94 | 1.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.26 on 02/29/24 | -2.53 on 02/27/24 | -0.57 on 02/26/24 | ||
| Latest Earnings Date | 05/08/24 | 05/03/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||